Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3EJ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,026
Award facts
- Contract value 100% obligated
- $17,026.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $17,026.10. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used in the treatment of overactive bladder, reflecting the breadth of pharmaceutical products the DLA procures to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated its capability to fulfill federal medical procurement requirements through consistent competitive awards across multiple therapeutic domains, supporting critical federal healthcare operations for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3EJ7?
SPE2DR26F3EJ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F3EJ7 worth?
The government has obligated $17,026 on SPE2DR26F3EJ7.
Is contract SPE2DR26F3EJ7 an order under another contract?
Yes. SPE2DR26F3EJ7 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3EJ7 competed?
The extent of competition for SPE2DR26F3EJ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award